1-5 of 5
E. Neely Atkinson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase III Prevention Trial of Fenretinide in Patients with Resected Non–Muscle-Invasive Bladder Cancer

Anita L. Sabichi, Seth P. Lerner, E. Neely Atkinson, H. Barton Grossman, Nancy P. Caraway, Colin P. Dinney, David F. Penson, Surena Matin, Ashish Kamat, Louis L. Pisters, Daniel W. Lin, Ruth L. Katz, Dean E. Brenner, George P. Hemstreet, III, Mary Wargo, Archie Bleyer, William H. Sanders, John L. Clifford, Howard L. Parnes, Scott M. Lippman
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (1): 224–229.
https://doi.org/10.1158/1078-0432.CCR-07-0733
Published: 02 January 2008
View article titled, Phase III Prevention Trial of Fenretinide in Patients with Resected Non–Muscle-Invasive Bladder Cancer
Open the PDF for Phase III Prevention Trial of Fenretinide in Patients with Resected Non–Muscle-Invasive Bladder Cancer in another window
Journal Articles

Transcriptional and Posttranscriptional Down-Regulation of the Imprinted Tumor Suppressor Gene ARHI (DRAS3) in Ovarian Cancer

Zhen Lu, Robert Z. Luo, Hongqi Peng, Daniel G. Rosen, E. Neely Atkinson, Carla Warneke, Maosheng Huang, Arata Nishmoto, Jinsong Liu, Warren S-L. Liao, Yinhua Yu, Robert C. Bast, Jr.
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (8): 2404–2413.
https://doi.org/10.1158/1078-0432.CCR-05-1036
Published: 25 April 2006
View article titled, Transcriptional and Posttranscriptional Down-Regulation of the Imprinted Tumor Suppressor Gene <em>ARHI</em> (<em>DRAS3</em>) in Ovarian Cancer
Open the PDF for Transcriptional and Posttranscriptional Down-Regulation of the Imprinted Tumor Suppressor Gene <em>ARHI</em> (<em>DRAS3</em>) in Ovarian Cancer in another window
Journal Articles

Results of a Phase II Double-Blinded Randomized Clinical Trial of Difluoromethylornithine for Cervical Intraepithelial Neoplasia Grades 2 to 3

Anne-Thérèse Vlastos, Loyd A. West, E. Neely Atkinson, Iouri Boiko, Anais Malpica, Waun K. Hong, Michele Follen
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (1): 390–396.
https://doi.org/10.1158/1078-0432.390.11.1
Published: 21 January 2005
View article titled, Results of a Phase II Double-Blinded Randomized Clinical Trial of Difluoromethylornithine for Cervical Intraepithelial Neoplasia Grades 2 to 3
Open the PDF for Results of a Phase II Double-Blinded Randomized Clinical Trial of Difluoromethylornithine for Cervical Intraepithelial Neoplasia Grades 2 to 3 in another window
Journal Articles

A Randomized Clinical Trial of 4-Hydroxyphenylretinamide for High-Grade Squamous Intraepithelial Lesions of the Cervix

Michele Follen, E. Neely Atkinson, David Schottenfeld, Anais Malpica, Loyd West, Scott Lippman, Changping Zou, Walter N. Hittelman, Reuben Lotan, Waun Ki Hong
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (11): 3356–3365.
Published: 01 November 2001
View article titled, A Randomized Clinical Trial of 4-Hydroxyphenylretinamide for High-Grade Squamous Intraepithelial Lesions of the Cervix
Open the PDF for A Randomized Clinical Trial of 4-Hydroxyphenylretinamide for High-Grade Squamous Intraepithelial Lesions of the Cervix in another window
Journal Articles

Quantitative Analysis of Transforming Growth Factor β1 and 2 in Ovarian Carcinoma

Mary Evelyn Gordinier, Hua-Zhong Zhang, Rebecca Patenia, Lawrence B. Levy, E. Neely Atkinson, Micheal A. Nash, Ruth L. Katz, Chris D. Platsoucas, Ralph S. Freedman
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (9): 2498–2505.
Published: 01 September 1999
View article titled, Quantitative Analysis of Transforming Growth Factor β1 and 2 in Ovarian Carcinoma
Open the PDF for Quantitative Analysis of Transforming Growth Factor β1 and 2 in Ovarian Carcinoma in another window